Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 03/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.11% | -1.68% | +43.40% | +95.58% | 66.93B | |
| +0.80% | -0.97% | +34.95% | +75.43% | 61.97B | |
| -1.85% | +2.39% | -10.67% | +379.45% | 28.26B | |
| +4.55% | +1.36% | +26.52% | +17.28% | 24.59B | |
| +2.27% | +0.18% | +0.98% | -13.15% | 24.3B | |
| +0.86% | -1.45% | +18.61% | -22.14% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +333.47% | 16.77B | |
| +3.44% | -1.88% | -5.46% | +547.21% | 14.18B | |
| +4.70% | +7.64% | -1.80% | +873.82% | 14B | |
| Average | +1.01% | -2.95% | +32.03% | +254.11% | 30.05B | |
| Weighted average by Cap. | +0.35% | -2.83% | +32.36% | +174.01% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
